Remarkable breakthroughs in diagnosing and treating disease have resulted in steady improvement in patient health, life expectancy and quality of life worldwide. Today, for example, we can translate a patient's unique tumour profile into a personalised cancer treatment. As a leader in oncology, Roche is committed to working with partners to ensure that patients have access to these essential treatments, while continuing to research and develop innovative medicines. Novel approaches are needed to address the complex issues impeding access to healthcare, especially for patients in developing countries. Roche's experience in China working with private insurance companies to develop private cancer insurance policies demonstrates how new thinking and comprehensive approaches can reduce barriers and expand access to quality healthcare.